Suppr超能文献

格雷夫斯病中的甲状腺三碘甲状腺原氨酸和甲状腺素:与术前治疗、甲状腺状态及碘含量的相关性

Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.

作者信息

Larsen P R

出版信息

J Clin Endocrinol Metab. 1975 Dec;41(06):1098-104. doi: 10.1210/jcem-41-6-1098.

Abstract

To evaluate the potential contribution of thyroidal secretion to the relative excess of triiodothyronine (T3) production in hyperthyroidism and to investigate the effects of treatment, iodine (127I), T3 and thyroxine (T4) were measured in digests of thyroid tissue obtained at surgery from 13 patients with Graves' disease. In 11 normal human thyroid glands, 127I content was 630 +/- 60 (all values mean +/- SE in mug/ wet weight) T4, 254 +/- 39 and T3 21 +/-3. The T4I was 26 +/- 3% of the total iodine and the molar ratio T4/T3 was 11 +/- 1. The 13 patients with Graves' disease were divided into three groups. Eleven were clinically euthyroid (Groups I and II) and had received either iodide or iodide plus a thiourea derivative before surgery. Two subjects (Group III) received only propranolol. In Group I (n = 8), mean thyroidal 127I content was 320 +/- 50, T4 was 115 +/- 9 and T3 22 +/- 4. The molar ratio T4/T3 was 5.9 +/- 1 and T4I was 26 +/- 2% of the total. Group II patients (3) had the lowest preoperative serum T4 (less than 2.5 mug/dl) and T3 (less than ng/dl) concentrations with TSH elevated in only one (7 muU/ml). Thyroidal 127I was 100 +/- 26, T49 +/- and T3 1.3 +/- 0.3. The % T4I was 5 +/-2. The two chemically hyperthyroid subjects had a mean tissue 127I of 450; T4, 295 and T3, 56, the T4/T3 ratio was 4.5 and % T4I was 42. There was no correlation between tissue 127I and T4/T3 within either the normal or Graves' disease group. Since adequate clinical and chemical control of hyperthyroidism with antithyroid drugs and iodine was attained in the 8 Group I subjects without a decrease in the % T4I or T3I below that of normal thyroids, it suggests that inhibition of iodotyrosine coupling is not required for this effect. The % T4I was below normal only in patients with marked suppression of serum T4 and T3 concentraions. The lack of correlation between tissue 127I and T4/T3 ratio in the treated patients suggests that the lower T4/T3 ratio in Graves' thyroids is independent of intrathyroidal iodine concentrations. This hypothesis is strengthened by the similarly low T4/T3 ratio in untreated subjects with near normal tissue 127I content. Assuming that the thyroid hormones are secreted in the ratios present in these digests, one can estimate that direct secretion by the thyroid could contribute most, of not all, of the excess T3 production in Graves' disease.

摘要

为评估甲状腺分泌对甲状腺功能亢进时三碘甲状腺原氨酸(T3)相对过量产生的潜在作用,并研究治疗效果,对13例格雷夫斯病患者手术时获取的甲状腺组织消化物中的碘(127I)、T3和甲状腺素(T4)进行了测定。11个正常人体甲状腺中,127I含量为630±60(所有数值均为微克/湿重的平均值±标准误),T4为254±39,T3为21±3。T4I占总碘的26±3%,T4/T3摩尔比为11±1。13例格雷夫斯病患者分为三组。11例临床甲状腺功能正常(I组和II组),术前接受过碘化物或碘化物加硫脲衍生物治疗。2例患者(III组)仅接受普萘洛尔治疗。I组(n = 8)甲状腺平均127I含量为320±50,T4为115±9,T3为22±4。T4/T3摩尔比为5.9±1,T4I占总量的26±2%。II组患者(3例)术前血清T4(低于2.5微克/分升)和T3(低于纳克/分升)浓度最低,仅1例TSH升高(7微单位/毫升)。甲状腺127I为100±26,T4为9±,T3为1.3±0.3。T4I百分比为5±2。2例化学性甲状腺功能亢进患者组织平均127I为450;T4为295,T3为56,T4/T3比值为4.5,T4I百分比为42。在正常组或格雷夫斯病组中,组织127I与T4/T3之间均无相关性。由于I组8例患者通过抗甲状腺药物和碘对甲状腺功能亢进进行了充分的临床和化学控制,但T4I或T3I百分比未降至低于正常甲状腺水平,这表明该效应不需要抑制碘酪氨酸偶联。仅在血清T4和T3浓度明显受抑制的患者中,T4I百分比低于正常。治疗患者中组织127I与T4/T3比值缺乏相关性,提示格雷夫斯甲状腺中较低的T4/T3比值与甲状腺内碘浓度无关。未经治疗、组织127I含量接近正常的受试者中T4/T3比值同样较低,这一假设得到了进一步支持。假设甲状腺激素按这些消化物中的比例分泌,则可以估计甲状腺直接分泌可能是格雷夫斯病中过量T3产生的主要原因(如果不是全部原因的话)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验